Children’s Miracle Network (CMN) awards grants to UC Davis Children’s Hospital for 2021-2023

Eleven grants totaling $352,554 have been awarded by Children’s Miracle Network (CMN) at UC Davis to clinicians and researchers at UC Davis Children’s Hospital. Grants in the amount of $152,554 will enhance the clinical care of children, while $200,000 was awarded for research directly improving the health and welfare of children.

Each year, applications are accepted by Children’s Miracle Network (CMN) for both clinical services and research grants. Each application must demonstrate how the project or research contributes to UC Davis Health Strategic Goals and/or UC Davis Medical Center Institutional Goals. The amount of funds awarded each year is determined by the CMN Executive Committee and chief executive officer of UC Davis Medical Center.

Clinical services grants funded for 2021-2023 for UC Davis Children’s Hospital:

• Extra-Corporeal Life Support (ECLS) simulation, high fidelity – Stephanie Mateev
• Pupillometer to assess critically ill children ­­– Sopon “Liz” North
• Ambulatory blood pressure monitoring for the diagnosis and management of pediatric hypertension – Stephanie Nguyen
• UC Davis Children’s Hospital pediatric inflammatory bowel disease (IBD) patient information guide – Daphne Say
• Joint effort between wound care and perioperative services to reduce pressure-related injuries in pediatric surgical patients – Jenni Prevatt
• Decreasing radiation exposure in pediatric PICC placement – Kathryn Garson
• Modern ultrasound to improve pediatric difficult intravenous access in the Department of Radiology – Douglas Wright

Research grants funded for 2021-2023 for UC Davis Children’s Hospital:

• Preductal Oxygen Saturation Target In Term (POST IT) and late preterm neonates with hypoxemic respiratory failure or pulmonary hypertension – Heather Siefkes
• Neurobehavioral and functional characterization of human CNKSR2-related disease in mouse and zebrafish animal model systems – Joseph Shen 
• Bowel and bladder function in the ovine myelomeningocele model – Maheen Hassan 
• Engineered placental mesenchymal stem cells as a cellular therapy vehicle for neuroblastoma treatment – Erin G. Brown, Dr. Anthony Philipps Award recipient 

Special consideration was given to junior faculty members and junior investigators. Faculty mentors reviewed the proposals prior to submission and included a letter of support and a current National Institutes of Health (NIH) biosketch, as applicable.